A Marek’s Disease Virus Messenger RNA-Based Vaccine Modulates Local and Systemic Immune Responses in Chickens
Viruses · 2024
DOI: 10.3390/v16071156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Fatemeh Fazel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada. Hauptthemen laut MEDLINE: Chickens, Marek Disease, Marek Disease Vaccines, Cytokines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada (NSERC), Ontario Agri-Food Innovation Alliance.
Abstract (Originalsprache)
Marek’s disease (MD), caused by the Marek’s disease virus, is a lymphoproliferative disease in chickens that can be controlled by vaccination. However, the current vaccines can limit tumor growth and death but not virus replication and transmission. The present study aimed to evaluate host responses following intramuscular injection of an mRNA vaccine encoding gB and pp38 proteins of the MDV within the first 36 h. The vaccine was injected in low and high doses using prime and prime-boost strategies. The expression of type I and II interferons (IFNs), a panel of interferon-stimulated genes, and two key antiviral cytokines, IL-1β and IL-2, were measured in spleen and lungs after vaccination. The transcriptional analysis of the above genes showed significant increases in the expression of MDA5, Myd88, IFN-α, IFN-β, IFN-γ, IRF7, OAS, Mx1, and IL-2 in both the spleen and lungs within the first 36 h of immunization. Secondary immunization increased expression of all the above genes in the lungs. In contrast, only IFN-γ, MDA5, MyD88, Mx1, and OAS showed significant upregulation in the spleen after the secondary immunization. This study shows that two doses of the MDV mRNA vaccine encoding gB and pp38 antigens activate innate and adaptive responses and induce an antiviral state in chickens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.
ORCID-Profile: Ayumi Matsuyama-Kato, Mohammadali Alizadeh, Charlotte Fletcher
Förderung
- Natural Sciences and Engineering Research Council of Canada (NSERC)
- Ontario Agri-Food Innovation Alliance
Zitieren
APA
Fazel, F., Matsuyama-Kato, A., Alizadeh, M., Zheng, J., Fletcher, C., Gupta, B., St-Denis, M., Boodhoo, N., & Sharif, S. (2024). A Marek’s Disease Virus Messenger RNA-Based Vaccine Modulates Local and Systemic Immune Responses in Chickens. Viruses. https://doi.org/10.3390/v16071156
Vancouver
Fazel F, Matsuyama-Kato A, Alizadeh M, Zheng J, Fletcher C, Gupta B, et al. A Marek’s Disease Virus Messenger RNA-Based Vaccine Modulates Local and Systemic Immune Responses in Chickens. Viruses. 2024. doi:10.3390/v16071156
BibTeX
@article{Fazel2024,
author = {Fazel, Fatemeh and Matsuyama-Kato, Ayumi and Alizadeh, Mohammadali and Zheng, Jiayu and Fletcher, Charlotte and Gupta, Bhavya and St-Denis, Myles and Boodhoo, Nitish and Sharif, Shayan},
title = {A Marek’s Disease Virus Messenger RNA-Based Vaccine Modulates Local and Systemic Immune Responses in Chickens},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16071156}
}
EUVIMED